Clorox (NYSE: CLX) reported Q4 EPS of $0.95, $0.41 worse than the analyst estimate of $1.36. Revenue for the quarter came in at $1.8 billion versus the consensus estimate of $1.92 billion.

GUIDANCE:

Clorox sees FY2022 EPS of $5.40-$5.70, versus the consensus of $7.61.

• 2% to 6% decrease in sales (2% to 6% decrease in organic sales)
• $5.05 to $5.35 diluted EPS range (9% to 4% decrease versus year ago)
• $5.40 to $5.70 adjusted EPS range (26% to 21% decrease versus year ago)Excludes the strategic investment in digital capabilities and productivity enhancements detailed below.
• Gross margin down by 300 to 400 basis points

For earnings history and earnings-related data on Clorox (CLX) click here.